경장영양 제제 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 플로우 유형별, 스테이지별, 적응증별, 최종 용도별, 판매채널별, 지역별, 부문 예측(2025-2030년)

Enteral Feeding Formulas Market Growth & Trends:

The global enteral feeding formulas market size is expected to reach USD 10.52 billion by 2030, registering a CAGR of 5.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is increasingly used for the personalized treatment of diseases, such as cancer and cystic fibrosis. These conditions require special nutrition to avoid any kind of drug interaction.

For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of these digestive enzymes can vary in individuals. Appropriate nutrition is critical for preterm infants, and early nutrition provision could influence better clinical outcomes & growth of the child, including neurodevelopment, decreased risk of Retinopathy of Prematurity (ROP), or prevention of Bronchopulmonary Dysplasia (BPD).

The commitment of NPOs and NGOs to preventing and caring for preterm birth, such as the 'Every Woman Every Child' movement of the UN, to advance the global strategy on women's and children's health, is expected to boost the demand for neonatal & preterm enteral feeding formulas. Growing initiatives to spread awareness regarding the importance of nutrients among the patient population are expected to improve the current market scenario.

According to an article titled ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week, published by ASPEN, around 10 hospitalized patients go undiagnosed every 60 seconds. Hence, this organization established Malnutrition Awareness Week in 2011 to spread awareness regarding malnutrition in hospitalized patients and educate healthcare professionals on the importance of nutrients among patients.

In case of medical necessity, Medicaid must cover enteral nutrition. However, there are no such regulations/mandates on private insurance companies. Moreover, as per the results of a survey conducted by NCBI, there is a huge lack of reimbursement for patients on Home Enteral Nutrition (HEN) and inadequate awareness among stakeholders regarding market opportunities, especially in lower-income countries.

Enteral Feeding Formulas Market Report Highlights:

• The standard formula segment led the market with the largest revenue share of 53.7% in 2024. The disease-specific formulas segment is expected to grow at the fastest CAGR during the forecast period.
• The intermittent feeding flow segment accounted for the largest revenue share in 2024. The continuous feeding flow segment is anticipated to grow at the fastest CAGR during the forecast period.
• The adult segment accounted for the largest market revenue share in 2024. The adult segment is also projected to grow at the fastest CAGR during the forecast period.
• The cancer care segment accounted for the largest market revenue share in 2024. The other indications segment is expected to grow at the fastest CAGR over the forecast period.
• The institutional sales segment accounted for the largest market revenue share in 2024. The online sales channel segment is projected to grow at the fastest CAGR over the forecast period.
• The home care segment accounted for the largest market revenue share in 2024. The hospital segment is anticipated to grow at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
  • 1.2.1. Information Procurement
• 1.3. Information or Data Analysis
• 1.4. Research Models
  • 1.4.1. Market Formulation & Validation
    • 1.4.1.1. Country Market: CAGR Calculation
  • 1.4.2. Country-based Segment Share Calculation
• 1.5. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Enteral Feeding Formulas Market Snapshot
• 2.2. Enteral Feeding Formulas Market Segment Snapshot
• 2.3. Enteral Feeding Formulas Market Competitive Landscape Snapshot

Chapter 3. Enteral Feeding Formulas Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
    • 3.2.1.1. Consumer Behavior Analysis
    • 3.2.1.2. Product Placement Framework
    • 3.2.1.3. Market Influencer Analysis
  • 3.2.2. Key End Users
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising geriatric population
    • 3.3.1.2. Growing prevalence of chronic diseases
    • 3.3.1.3. Shifting trend toward consumption of disease-specific formulas
    • 3.3.1.4. Growing demand for neonatal and preterm enteral feeding
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of awareness in the medical community
    • 3.3.2.2. Improper categorization of clinical nutrition
  • 3.3.3. Industry Challenges
    • 3.3.3.1. Complications associated with small-bore connectors
    • 3.3.3.2. Risks associated with enteral feeding
• 3.4. Enteral Feeding Formulas Market Analysis Tools
  • 3.4.1. Enteral Feeding Devices Market - Pestle Analysis
  • 3.4.2. Industry Analysis - Porter's Five Forces
• 3.5. COVID-19 Impact on Enteral Feeding Formulas Market

Chapter 4. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2.1. Standard Formula
    • 4.2.1.1. Standard Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Disease-specific Formula
    • 4.2.2.1. Disease-specific Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2.2. Alzheimer's Disease
      • 4.2.2.2.1. Disease Specific Formulas Market Estimates And Forecasts, For Alzheimer's Disease, 2018 - 2030 (USD Million)
    • 4.2.2.3. Nutrition Deficiency
      • 4.2.2.3.1. Disease Specific Formulas Market Estimates And Forecasts, For Nutrition Deficiency, 2018 - 2030 (USD Million)
    • 4.2.2.4. Cancer Care
      • 4.2.2.4.1. Disease Specific Formulas Market Estimates And Forecasts, For Cancer Care, 2018 - 2030 (USD Million)
    • 4.2.2.5. Diabetes
      • 4.2.2.5.1. Disease Specific Formulas Market Estimates And Forecasts, For Diabetes, 2018 - 2030 (USD Million)
    • 4.2.2.6. Chronic Kidney Diseases
      • 4.2.2.6.1. Disease Specific Formulas Market Estimates And Forecasts, For Chronic Kidney Diseases, 2018 - 2030 (USD Million)
    • 4.2.2.7. Orphan Diseases
      • 4.2.2.7.1. Disease Specific Formulas Market Estimates And Forecasts, For Orphan Diseases, 2018 - 2030 (USD Million)
    • 4.2.2.8. Dysphagia
      • 4.2.2.8.1. Disease Specific Formulas Market Estimates And Forecasts, For Dysphagia, 2018 - 2030 (USD Million)
    • 4.2.2.9. Pain Management
      • 4.2.2.9.1. Disease Specific Formulas Market Estimates And Forecasts, For Pain Management, 2018 - 2030 (USD Million)
    • 4.2.2.10. Malabsorption/GI Disorder/Diarrhea
      • 4.2.2.10.1. Disease Specific Formulas Market Estimates And Forecasts, For Malabsorption/GI Disorder/Diarrhea, 2018 - 2030 (USD Million)
    • 4.2.2.11. Others
      • 4.2.2.11.1. Disease Specific Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)

Chapter 5. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.2.1. Intermittent Feeding Flow
    • 5.2.1.1. Intermittent Feeding Flow Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Continuous Feeding Flow
    • 5.2.2.1. Continuous Feeding Flow Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
• 6.3. Adult
  • 6.3.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Pediatric
  • 6.4.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 7.2.1. Alzheimer's Disease
    • 7.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Alzheimer's Disease, 2018 - 2030 (USD Million)
  • 7.2.2. Nutrition Deficiency
    • 7.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Nutrition Deficiency, 2018 - 2030 (USD Million)
  • 7.2.3. Cancer Care
    • 7.2.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Cancer Care, 2018 - 2030 (USD Million)
  • 7.2.4. Diabetes
    • 7.2.4.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Diabetes, 2018 - 2030 (USD Million)
  • 7.2.5. Chronic Kidney Diseases
    • 7.2.5.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Chronic Kidney Diseases, 2018 - 2030 (USD Million)
  • 7.2.6. Orphan Diseases
    • 7.2.6.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Orphan Diseases, 2018 - 2030 (USD Million)
  • 7.2.7. Dysphagia
    • 7.2.7.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Dysphagia, 2018 - 2030 (USD Million)
  • 7.2.8. Pain Management
    • 7.2.8.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Pain Management, 2018 - 2030 (USD Million)
  • 7.2.9. Malabsorption/GI Disorder/Diarrhea
    • 7.2.9.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Malabsorption/Gi Disorder/Diarrhea, 2018 - 2030 (USD Million)
  • 7.2.10. Others
    • 7.2.10.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)

Chapter 8. Enteral Feeding Formulas Market: End User Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Enteral Feeding Formulas Market: End User Movement Analysis, 2023 & 2030 (USD Million)
  • 8.2.1. Hospitals
    • 8.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Hospitals, 2018 - 2030 (USD Million)
    • 8.2.1.2. Cardiology
      • 8.2.1.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Cardiology, 2018 - 2030 (USD Million)
    • 8.2.1.3. Neurology
      • 8.2.1.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Neurology, 2018 - 2030 (USD Million)
    • 8.2.1.4. Critical Care (ICU)
      • 8.2.1.4.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Critical Care (ICU), 2018 - 2030 (USD Million)
    • 8.2.1.5. Oncology
      • 8.2.1.5.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Oncology, 2018 - 2030 (USD Million)
    • 8.2.1.6. Others
      • 8.2.1.6.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)
  • 8.2.2. Home Care
    • 8.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Home Care, 2018 - 2030 (USD Million)

Chapter 9. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 9.2.1. Online
    • 9.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Online Sales Channel, 2018 - 2030 (USD Million)
  • 9.2.2. Retail
    • 9.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Retail Sales Channel, 2018 - 2030 (USD Million)
  • 9.2.3. Institutional Sales
    • 9.2.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Institutional Sales Channel, 2018 - 2030 (USD Million)

Chapter 10. Enteral Feeding Formulas Market: Regional Estimates & Trend Analysis

• 10.1. Enteral Feeding Formulas Market: Regional Movement Analysis, 2023 & 2030
• 10.2. North America
  • 10.2.1. North America Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.2. U.S.
    • 10.2.2.1. Key Country Dynamics
    • 10.2.2.2. Prevalence Insights
    • 10.2.2.3. Regulatory Framework
    • 10.2.2.4. U.S. Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.3. Canada
    • 10.2.3.1. Key Country Dynamics
    • 10.2.3.2. Prevalence Insights
    • 10.2.3.3. Regulatory Framework
    • 10.2.3.4. Canada Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.4. Mexico
    • 10.2.4.1. Key Country Dynamics
    • 10.2.4.2. Prevalence Insights
    • 10.2.4.3. Regulatory Framework
    • 10.2.4.4. Mexico Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.3. Europe
  • 10.3.1. Europe Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.2. UK
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Prevalence Insights
    • 10.3.2.3. Regulatory Framework
    • 10.3.2.4. UK Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.3. Germany
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Prevalence Insights
    • 10.3.3.3. Regulatory Framework
    • 10.3.3.4. Germany Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.4. France
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Prevalence Insights
    • 10.3.4.3. Regulatory Framework
    • 10.3.4.4. France Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.5. Italy
    • 10.3.5.1. Key Country Dynamics
    • 10.3.5.2. Prevalence Insights
    • 10.3.5.3. Regulatory Framework
    • 10.3.5.4. Italy Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.6. Spain
    • 10.3.6.1. Key Country Dynamics
    • 10.3.6.2. Prevalence Insights
    • 10.3.6.3. Regulatory Framework
    • 10.3.6.4. Spain Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.7. Denmark
    • 10.3.7.1. Key Country Dynamics
    • 10.3.7.2. Prevalence Insights
    • 10.3.7.3. Regulatory Framework
    • 10.3.7.4. Denmark Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.8. Sweden
    • 10.3.8.1. Key Country Dynamics
    • 10.3.8.2. Prevalence Insights
    • 10.3.8.3. Regulatory Framework
    • 10.3.8.4. Sweden Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.9. Norway
    • 10.3.9.1. Key Country Dynamics
    • 10.3.9.2. Prevalence Insights
    • 10.3.9.3. Regulatory Framework
    • 10.3.9.4. Norway Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.4. Asia Pacific
  • 10.4.1. Asia Pacific Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.2. Japan
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Prevalence Insights
    • 10.4.2.3. Regulatory Framework
    • 10.4.2.4. Japan Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.3. China
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Prevalence Insights
    • 10.4.3.3. Regulatory Framework
    • 10.4.3.4. China Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.4. India
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Prevalence Insights
    • 10.4.4.3. Regulatory Framework
    • 10.4.4.4. India Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.5. South Korea
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Prevalence Insights
    • 10.4.5.3. Regulatory Framework
    • 10.4.5.4. South Korea Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.6. Australia
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Prevalence Insights
    • 10.4.6.3. Regulatory Framework
    • 10.4.6.4. Australia Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.7. Thailand
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Prevalence Insights
    • 10.4.7.3. Regulatory Framework
    • 10.4.7.4. Thailand Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.5. Latin America
  • 10.5.1. Latin America Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5.2. Brazil
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Prevalence Insights
    • 10.5.2.3. Regulatory Framework
    • 10.5.2.4. Brazil Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5.3. Argentina
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Prevalence Insights
    • 10.5.3.3. Regulatory Framework
    • 10.5.3.4. Argentina Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.6. Middle East & Africa
  • 10.6.1. Middle East & Africa Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.2. South Africa
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Prevalence Insights
    • 10.6.2.3. Regulatory Framework
    • 10.6.2.4. South Africa Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.3. Saudi Arabia
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Prevalence Insights
    • 10.6.3.3. Regulatory Framework
    • 10.6.3.4. Saudi Arabia Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.4. UAE
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Prevalence Insights
    • 10.6.4.3. Regulatory Framework
    • 10.6.4.4. UAE Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.5. Kuwait
    • 10.6.5.1. Key Country Dynamics
    • 10.6.5.2. Prevalence Insights
    • 10.6.5.3. Regulatory Framework
    • 10.6.5.4. Kuwait Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis, By Key Market Participants
• 11.2. Company Categorization
• 11.3. Vendor Landscape
  • 11.3.1. Key Customers
• 11.4. Key Company Market Share Analysis
• 11.5. Company Market Position Analysis
• 11.6. Company Market Ranking
  • 11.6.1. Regional Network Map
• 11.7. Company Profiles/Listing
  • 11.7.1. Abbott
    • 11.7.1.1. Overview
    • 11.7.1.2. Financial Performance (Net Revenue)
    • 11.7.1.3. Product Benchmarking
    • 11.7.1.4. Strategic Initiatives
  • 11.7.2. Danone S.A
    • 11.7.2.1. Overview
    • 11.7.2.2. Financial Performance (Net Revenue)
    • 11.7.2.3. Product Benchmarking
    • 11.7.2.4. Strategic Initiatives
  • 11.7.3. Fresenius Kabi AG
    • 11.7.3.1. Overview
    • 11.7.3.2. Financial Performance (Net Revenue)
    • 11.7.3.3. Product Benchmarking
    • 11.7.3.4. Strategic Initiatives
  • 11.7.4. Nestle
    • 11.7.4.1. Overview
    • 11.7.4.2. Financial Performance (Net Revenue)
    • 11.7.4.3. Product Benchmarking
    • 11.7.4.4. Strategic Initiatives
  • 11.7.5. VICTUS
    • 11.7.5.1. Overview
    • 11.7.5.2. Financial Performance (Net Revenue)
    • 11.7.5.3. Product Benchmarking
    • 11.7.5.4. Strategic Initiatives
  • 11.7.6. Primus Pharmaceuticals, Inc.
    • 11.7.6.1. Overview
    • 11.7.6.2. Financial Performance (Net Revenue)
    • 11.7.6.3. Product Benchmarking
    • 11.7.6.4. Strategic Initiatives
  • 11.7.7. Meiji Holdings. Co., Ltd.
    • 11.7.7.1. Overview
    • 11.7.7.2. Financial Performance (Net Revenue)
    • 11.7.7.3. Product Benchmarking
    • 11.7.7.4. Strategic Initiatives
  • 11.7.8. Mead Johnson & Company, LLC
    • 11.7.8.1. Overview
    • 11.7.8.2. Financial Performance (Net Revenue)
    • 11.7.8.3. Product Benchmarking
    • 11.7.8.4. Strategic Initiatives
  • 11.7.9. Alcresta Therapeutics
    • 11.7.9.1. Overview
    • 11.7.9.2. Financial Performance (Net Revenue)
    • 11.7.9.3. Product Benchmarking
    • 11.7.9.4. Strategic Initiatives